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Abstract
Excessive risky decision-making is common in multiple psychiatric disorders, including
substance abuse disorder. The risky decision-making task (RDT) models addiction-relevant risktaking in rats by measuring preference between a small reward and large reward associated with
systematically increasing risk of shock. This Thesis examined the relationship between risktaking in the RDT and multiple cognitive and neurobiological addiction-relevant phenotypes.
Risk-taking was associated with elevated impulsive action, but not impulsive choice or habit
formation. Furthermore, risk-taking predicted locomotor sensitivity to first-time nicotine
exposure and resilience to nicotine-evoked anxiety. Finally, risk-taking was associated with
elevated phasic dopamine release and sensitivity to the dopamine transporter inhibitor
nomifensine in the nucleus accumbens. Collectively, these data demonstrate that risk preference
in the RDT predicts a cluster of traits associated with substance abuse, and may have utility for
identification of neurobiological and genetic biomarkers that engender addiction vulnerability.
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Risky decision-making is the pursuit of reward despite the possibility of aversive
outcomes. While some risk-taking can be beneficial, excessive risk-taking is often maladaptive,
and is observed across many psychiatric illnesses (Bechara et al., 2001). Risky decision-making
is particularly prevalent in substance abuse disorders, as drug abusers tend to continue seeking
drug rewards despite the risk of physical, social, and financial consequences (Brand, Roth-Bauer,
Driessen, & Markowitsch, 2008; Brevers et al., 2014; Lane & Cherek, 2000). The ability to
identify individuals predisposed toward pathological risk-taking may facilitate preventative
therapeutic intervention prior to the onset of addiction. Furthermore, understanding the
behavioral and neuronal underpinnings of risky decision-making may have utility toward
development of novel treatments that target aberrant decision-making processes in substance
abusers.
Rationale for the RDT as a rodent model of risky decision-making
Animal models of risky decision-making offer a level of experimental control and
technical precision unavailable in clinical research (Kim, Adhikari, & Deisseroth, 2017). Thus,
development of an animal task with high construct validity for measuring real-world risky
decision-making has been of high priority. Two common measures of risk-taking behavior are
the light-dark task and the elevated plus maze (EPM) (Arrant, Schramm-Sapyta, & Kuhn, 2013;
Macrì, Adriani, Chiarotti, & Laviola, 2002). In the light-dark task, rats are placed in a chamber
with a dark room, an illuminated room, and an opening between the two. Exploration of the light
room is used as a measure of risk-taking. The EPM is a raised platform consisting of two
enclosed arms and two open arms crossed at the middle. In this task, exploratory behavior of the
open arms serves as a risk-taking measurement. Both tasks quantify risk-taking as exploratory
behavior of a potentially dangerous situation. However, there is no tangible risk component
because there is no potential for aversive outcomes following exploratory behavior. These tasks
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also suffer from a lack of test-retest ability due to rats becoming habituated after a single session
(Bourin, 2015). Finally, baseline anxiety is a major confound, as an increased anxious state will
decrease exploratory behavior (Belzung, 1999).
The most common preclinical measurement of risky decision-making in recent history is
probability discounting, an economic decision-making task in which animals choose between a
large or small reward, with the probability of large reward delivery decreasing across the session
(Caitlin A. Orsini, Moorman, Young, Setlow, & Floresco, 2015). While a more valid measure of
risk-taking than exploratory tasks, probability discounting still lacks salient consequences. Rats
that do not receive the probabilistic reward lose the potential for reward, but do not experience
any explicit punishment or relinquishment of reward. Additionally, in probability discounting the
reward and punishment share the same modality, either receipt or omission of reward. This
makes the task a useful measure of gambling behavior, in which rewards and consequences are
both financial, but less so for substance abuse relevant decision-making in which reward and
consequence are often distinct. For example, snorting cocaine is physically rewarding, but a
failed drug test can lead to the loss of your job. Finally, probability discounting contains a
working memory component, as there is an ostensibly “correct” choice throughout the majority
of the task. For example, choosing the probabilistic reward in the 25% delivery condition has a
lower overall yield than choosing the small, certain reward (.75 pellets/trial vs 1 pellet/ trial).
The rat risky decision-making task (RDT) was developed to more effectively model realworld risk-taking (N. W. Simon, Gilbert, Mayse, Bizon, & Setlow, 2009). During this task, rats
choose between a small, safe reward and a large, risky reward accompanied by the chance of a
mild foot shock. The risk of punishment increases throughout the session, which allows a
measurement of economic decision-making across multiple levels of risk. The RDT differs from
the aforementioned risk tasks in several important ways. First, it includes the risk of punishment,
8

whereas exploratory tasks such as the light-dark or elevated plus maze have no consequences.
Second, the RDT offers greater external validity than probability discounting by differing the
modality of risk and reward, as real-world punishments are often unrelated to rewards. Finally,
there is no “correct” choice in the RDT in terms of overall economic value as there is in
probability discounting, as the risky choice consistently yields greater reward but also may yield
physical punishment, which subjectively reduces the value of this option (Caitlin A. Orsini et al.,
2015).
During RDT, as risk of punishment increases, risk preference generally decreases (N. W.
Simon & Setlow, 2012). Somewhat surprisingly, a subset of individuals consistently demonstrate
preference for the large reward regardless of risk level (Mitchell et al., 2014; Shimp, Mitchell,
Beas, Bizon, & Setlow, 2015; N. W. Simon et al., 2011, 2009). Importantly, this “risk-taking”
phenotype is independent of mitigating factors such as pain tolerance, reward motivation, or
anxiety (N. W. Simon et al., 2011). A similar insensitivity to risk of consequences is commonly
observed in substance abuse (Brevers et al., 2014; Verdejo-Garcia, Chong, Stout, Yucel, &
London, 2016). Thus, understanding the neurobiological and cognitive distinctions that
predispose this subpopulation of rats toward risk-taking in the RDT may provide insight into
mechanisms underlying addiction vulnerability. The experiments conducted in this thesis
assessed behavioral and pharmacological characteristics that are evident in these risk-taking rats,
with a focus on phenotypes commonly observed in addiction.
Phenotypic Distinctions of Risk-Taking Rats
Previous research has provided evidence that rats that prefer risky rewards on the RDT
exhibit distinct behavioral and biological differences from the remainder of the population, some
of which are often comorbid with substance abuse disorders. Adolescent risk-taking rats exhibit
9

elevated cocaine self-administration compared to risk-averse subjects, which indicates increased
sensitivity to psychostimulant drugs of abuse (Mitchell et al., 2014). In humans adolescents, risktaking is associated with low working memory (Romer et al., 2009, 2011). In the RDT, however
low working memory is actually associated with hyper risk-averse rats (Shimp et al., 2015).
Risk-takers also attribute greater salience to reward-predictive cues, a motivational phenotype
that engenders cue-induced drug seeking and relapse (Flagel, Akil, & Robinson, 2009;
Olshavsky et al., 2014).
Distinct neurobiological factors have also been observed in risk-taking rats. Risk-taking
in the RDT coincides with increased D1 receptor expression in the NAc shell (NAcs), but not
core, subregion (Mitchell et al., 2014; N. W. Simon et al., 2011). The NAc is critical in the
integration of motivational signals to direct behavior, and has been implicated in both risky
decision-making and addiction formation (Ikemoto & Panksepp, 1999; Lyness, Friedle, &
Moore, 1979; Matthews, Simmons, Lane, & Paulus, 2004). D1 receptors have been shown to act
on the central mechanisms governing consumption of natural rewards, i.e. food intake (Terry,
Gilbert, & Cooper, 1995). Increased D1 receptor populations indicate enhanced dopaminergic
signaling in the mesolimbic reward pathway, which drives reward related incentive learning and
is associated with substance abuse and addiction (Beninger & Miller, 1998; Luscher & Malenka,
2011). Risk-taking rats also exhibit increased D1 receptor expression in the insular cortex (INS)
(N. W. Simon et al., 2011). The INS plays a major role in encoding the emotional attributes of
anticipated outcomes, which drives craving for drugs of abuse in the presence of associated cues
(Droutman, Read, & Bechara, 2015). Moreover, the INS provides mental representations of
imagined painful events in humans (Ogino et al., 2007), indicating that this region likely
mediates decision-making under the risk of impending physical punishment (as in RDT). D1
receptors in the INS also play a role in encoding the motivational value of drugs, which can drive
10

drug-seeking behavior (Kutlu et al., 2013; Pietro, Mashhoon, Heaney, Yager, & Kantak, 2010).
Collectively, these data taken from NAC and INS suggest that risk-taking rats may be
hypersensitive to reward, which may increase vulnerability to substance abuse in this population.
In addition to enhanced D1 receptor expression in the NAcs and INS, risk taking rats
express diminished D2 receptor populations in the dorsal striatum (DS), a region responsible for
consolidating goal-directed behaviors into habits (B. J. Everitt et al., 2008; N. W. Simon et al.,
2011). A comparable dopaminergic abnormality is also observed in human substance abusers
(Volkow, Fowler, Wang, Swanson, & Telang, 2007). D2 receptors are inhibitory; therefore,
reduced D2 receptor availability would enhance overall DS output, which may accelerate habit
formation in risk-taking rats (Obadiah et al., 1999). The devolution of reward-seeking behavior
from goal-directed to habitual is fundamental in the development of substance abuse (Barry J.
Everitt & Robbins, 2016).
The experiments conducted in this thesis further probed the behavioral and
neurobiological characteristics of risk-taking rats, with a focus on phenotypes related to
addiction susceptibility. First, we tested if risk-taking rats are more impulsive than the rest of the
population, and if this pattern is observed across multiple forms of impulsivity. Next, we tested if
risk-taking rats shift to habitual reward-seeking behavior more quickly than the rest of the
population. Then, we tested sensitivity to the psychostimulant of abuse nicotine in risk-taking
rats. Finally, we assessed phasic dopamine dynamics in the NAc of risk-takers. This battery of
experiments served the two-fold purpose of 1.) determining the behavioral and biological
mechanisms that contribute to risky behavior, and 2.) establishing risk-taking rats identified
through the RDT as a model that captures several aspects of addiction vulnerability.
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Risky Decision-Making and Impulsivity
Impulsivity is broadly defined as a tendency to perform actions rapidly and prematurely
without appropriate forethought despite the possibility of undesirable consequences (Jeffrey W.
Dalley & Robbins, 2017). Excessive impulsivity is observed across multiple psychiatric
disorders, including substance abuse (Bickel, Johnson, Koffarnus, MacKillop, & Murphy, 2014;
Goldstein et al., 2009; MacKillop et al., 2010). Impulsivity is a multifaceted behavioral construct
that can be fractioned into impulsive action, a lack of self-control, and impulsive choice, delay
discounting (Jeffrey W. Dalley & Robbins, 2017).
Impulsive action is operationalized as the inability to withhold a prepotent response in the
pursuit of reward (Jeffrey W. Dalley & Robbins, 2017). We hypothesized that impulsive action
would be comorbid with risky decision-making for three reasons: 1.) Ongoing choice of the large
reward despite risk of consequences may be a function of impaired response inhibition, 2.) both
impulsive action and risk-taking have been shown to be associated with increased cocaine selfadministration in a rat model (J. W. Dalley et al., 2007; Mitchell et al., 2014), and 3.) impulsive
action and excessive risk-taking are both associated with increased D1 receptor expression in the
NAcs (Pezze, Dalley, & Robbins, 2007; N. W. Simon et al., 2011, 2013). We quantified the
relationship between these phenotypes by comparing risk taking in the RDT with performance in
the differential reinforcement of low rates of responding (DRL) task. In the DRL, a set time must
elapse before a response is rewarded. A response before this time elapses resets the timer,
leading to reduced opportunity for reward for impulsive subjects (Doughty & Richards, 2002).
Impulsive choice, or delay discounting, is defined as preference for immediate
gratification over delayed rewards (Catharine A Winstanley, Theobald, Dalley, & Robbins,
2005). Excessive discounting of delayed rewards is commonly associated with substance use
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disorders, and decreasing delay discounting has shown promise for attenuating substance abuse
(Bickel, Johnson, et al., 2014; Murphy et al., 2012). Additionally, training to decrease impulsive
choice in humans also diminishes risk-taking (Romer, Duckworth, Sznitman, & Park, 2010).
Despite these commonalities, previous studies have shown that impulsive choice is unrelated to
RDT performance (Shimp et al., 2015; N. W. Simon et al., 2013), despite sharing some common
neurobiological substrates (C. A. Orsini, Trotta, Bizon, & Setlow, 2015; Roesch, Taylor, &
Schoenbaum, 2006; C. A. Winstanley, 2004). Indeed, while impulsive choice shares some
neuronal overlap with impulsive action, the two constructs are often uncorrelated and have
distinct substrates (Rudolf N. Cardinal, 2006; N. W. Simon et al., 2013; Catharine A.
Winstanley, Eagle, & Robbins, 2006). Furthermore, it has been found that risk-taking as assessed
by the Balloon Analogue Risk Task (BART) may provide a better predictor than impulsivity for
use of some drugs of abuse, specifically alcohol (Aklin, Lejuez, Zvolensky, Kahler, & Gwadz,
2005; Fernie, Cole, Goudie, & Field, 2010).Therefore, we did not expect to observe a
relationship between risk-taking behavior and impulsive choice. To confirm this, rats were
trained in a delay-discounting task, in which they had a choice between a small immediate
reward and a large reward delivered after a delay that systematically increases throughout the
session. Impulsive choice behavior was then compared to risky decision-making.

Habit Formation and Risky Decision-Making
Habitual behavior is defined as inability to alter behavior in response to changes in
action-outcome relationships (Balleine & Dickinson, 1998). Habits are strengthened from the
repetition of reinforced actions, which can include drug seeking or taking (Balleine & Dickinson,
1998). The rewarding nature of drugs of abuse in tandem with the inflexibility of habitual
13

behavior makes breaking drug addiction an arduous task (Hogarth, Balleine, Corbit, & Killcross,
2013; Winehouse, Ronson, & Records, 2006).
It is possible that the persistent choice of rewards associated with negative outcomes in
risk-taking rats may be a function of increased rate of habit formation. This hypothesis is
supported by the attenuation of D2 receptors in the DS of risk-takers (N. W. Simon et al., 2011).
The DS is commonly associated with the formation of habits during repetitive reward seeking for
both natural and drug rewards and the phenotypic distinction found in risk-taking rats is also
commonly seen in human addicts as well (B. J. Everitt et al., 2008; Poldrack & Packard, 2003;
Robbins, Ersche, & Everitt, 2008; Volkow et al., 2007). Because D2 receptors are inhibitory,
diminished D2 expression in the DS of risk-taking rats likely disinhibits that region, accelerating
the shift towards habitual behavior (Obadiah et al., 1999). Together, with the lack of
adaptation to changing action-outcome contingencies during RDT, these data suggest that
risk-taking rats may be more prone to habit formation.
To assess habit formation, we trained rats in a reinforcer devaluation task (LeBlanc,
Maidment, & Ostlund, 2013). In this task, rats trained extensively on a variable-interval 60 (VI60) protocol to establish consistent reward seeking. They were then given free access to the
reinforcer for one hour to induce outcome-specific satiation (which devalues the reinforcer), after
which they ran an identical VI-60 task in extinction to assess the degree to which their behavior
shifted away from a goal-orientation to a stimulus-response orientation. The degree of seeking
the devalued reward was compared to risk-taking behavior in the RDT.

Nicotine Sensitization and Risky Decision-Making
Drug-evoked locomotion is an easily quantifiable measure of psychostimulant sensitivity,
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with enhanced locomotor activation indicative of increased sensitivity (Benwell & Balfour,
1992; Nisell, Nomikos, Hertel, & Panagis, 1996; Panagis, Nisell, Nomikos, Chergui, &
Svensson, 1996). Nicotine is an addictive psychostimulant commonly shown to enhance
locomotion and evoked dopamine release in the NAc (Panagis et al., 1996). Repeated exposure
to nicotine has been shown to increase locomotor sensitivity to the drug (Cadoni & Di Chiara,
2000). This phenomenon, referred to as locomotor sensitization, is associated with greater drug
seeking and craving. Moreover, sensitization is often more pronounced after a period of drug
cessation, which may play a role in the commonality of relapse in abstinent drug addicts
(Shaham, Shalev, Lu, De Wit, & Stewart, 2003).
Sensitization to drugs of abuse is indicative of mesocortical dopaminergic changes that
may be exacerbated in risk-taking rats. Sensitization is associated with D1 receptor supersensitivity in the NAc (Shaham et al., 2003), and risk-taking rats have a high abundance of D1
receptors in NAc (Simon et al., 2011). D1 receptor activation increases nicotine reinforcement
and nicotine induces NAc dopaminergic activity, indicating that risk-taking rats may be
especially susceptible to nicotine’s addictive properties (Laviolette, Lauzon, Bishop, Sun, & Tan,
2008; Panagis et al., 1996). Thus, we predicted that risk-taking rats would be more sensitive to
the locomotor activating effects of nicotine.
Here, we assessed sensitivity to nicotine in risk-taking rats by passively administering
nicotine according to a schedule previously shown to induce sensitization (Bueno-Junior, Simon,
Wegener, & Moghaddam, 2017). We predicted that risk-taking rats would exhibit enhanced
nicotine-evoked locomotor activation and behavioral sensitization compared to the rest of the
population.
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Dopaminergic Differences in Risk-Taking Rats
Past research has shown differences in region-specific dopamine receptor expression of
risk-taking rats (Mitchell et al., 2014; N. W. Simon et al., 2011). However, this does not inform
us about biologically relevant dopamine signaling. Phasic dopamine activity, a spike in synaptic
dopamine release caused by burst firing of dopamine neurons in the midbrain, is evoked by
exposure to rewards and reward-predicting stimuli (Floresco, West, Ash, Moore, & Grace,
2003). Therefore, understanding differences in phasic dopamine activity is critical for
understanding the mechanisms of reward-motivated decision-making.
Fixed potential amperometry (FPA) is a technique used to monitor sub-second dopamine
release by recording current change as dopamine oxidizes. FPA can simulate phasic dopamine
release through brief electrical stimulation of dopamine neurons projecting to the target region
(Lester, Rogers, & Blaha, 2010). Using this technique, we examined differences in phasic
dopamine activity in risk-taking rats.
Dopaminergic activity in the NAc drives motivation for natural and drug rewards
(Ikemoto & Panksepp, 1999). Additionally, phasic dopamine release in the core of the NAc was
predictive of reward preference during a probabilistic decision-making task (Sugam, Day,
Wightman, & Carelli, 2012). Thus, greater reward-evoked phasic dopamine activity is likely
linked to addiction vulnerability, and the increased expression D1 receptors in the NAcs
indicates a possible behavioral bias towards reward-seeking (Barr & Phillips, 1999; Beninger &
Miller, 1998). It is currently unknown whether enhanced D1 receptor expression is due to
enhanced dopamine activity or compensation for attenuated dopamine activity. To explore this,
we used FPA to record evoked dopamine release and dopamine supply in NAc of risk-taking rats
compared to the rest of the population.
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Cocaine increases synaptic dopamine by blocking the dopamine transporter (DAT) to
inhibit dopamine reuptake (Mcelvain & Schenk, 1992). Risk-taking rats are more sensitive to
cocaine reinforcement, as they self-administer more cocaine than risk-averse rats (Mitchell et al.,
2014). This difference in sensitivity to cocaine suggests abnormal DAT function in risk-takers.
We addressed this by measuring the impact of the DAT inhibitor nomifensine (Carboni,
Imperato, Perezzani, & Di Chiara, 1989) on synaptic dopamine in NAc. Reduced DAT
efficiency attenuates ability to clear dopamine from the synapse, which would engender
enhanced overall motivation for natural rewards as well as drugs of abuse (Sonders, Zhu,
Zahniser, Kavanaugh, & Amara, 1997; Torres, Gainetdinov, & Caron, 2003).
We hypothesized that risk-taking rats would exhibit increased phasic dopamine
release and dopamine supply compared to the rest of the population. We also predicted
enhanced dopamine half-life after nomifensine treatment, indicative of reduced DAT
efficiency.

Summary of Experiments
This thesis consisted of three experiments to identify differences in cognition,
psychostimulant sensitivity, and dopaminergic signaling in risk-taking rats. For Experiment 1,
we characterized all rats in risk preference, impulsive action, impulsive choice, and habitual
behavior. Behaviorally characterized rats were then tested in either nicotine sensitization
(Experiment 2) or fixed potential amperometry to measure dopamine release in NAc
(Experiment 3). See Figure 1 for full experimental timeline.
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Figure 1: Experimental Timeline. Order of behavioral measures will be counterbalanced across
rats.

Methods
Subjects
Male Long-Evans rats were be obtained from Envigo Corp. Rats arrived pair-housed and
kept on a 12-hour light/dark cycle beginning with lights off at 8am. Rats had ad libitum access to
water. They were food restricted to 90% free feeding baseline weight to increase motivation to
pursue the reward in behavioral tasks. Pairs were separated if fighting or food domination is
observed.

Experiment 1: Relationship between risk-taking and cognition
Behavioral Apparatus
Behavior and decision-making processes were be measured in MedAssociates (FairFax,
VA) operant conditioning chambers equipped with one retractable lever on either side of an
illuminable food trough, pellet dispenser, and shock grate. Tailor-made MedAssociates codes
18

were used to run all behavioral protocols.

Figure 2. Example Operant Chamber. A centered food trough is flanked by two levers.

Risky Decision-Making Task
For every behavioral comparison, rats were run in RDT to determine risk-preference.
Critically, the order of tasks in experiment 1 was counterbalanced across subjects, with some rats
beginning with RDT, others beginning with a different task (see below).
Initial shaping was adapted from past experiments (N. W. Simon, Mendez, & Setlow,
2007). Briefly, rats (n=75) were trained to associate the food trough with food delivery, initiate
lever extension with a food trough entry, and press both levers to receive food reward. They then
learned to discriminate between the large (3 pellet) and the small (1 pellet) reward leavers. Upon
demonstrating consistent preference for the large reward, they began training in the RDT. The
RDT consisted of 5 blocks of 18 trials, totaling 90 trials per session. Each block began with 8
forced trials (single lever) followed by 10 choice trials (dual lever). Forced choice trials served to
establish new risk contingencies upon initiation of each new block. During forced choice trials,
19

lever presentation was pseudorandomized, with the same lever never extended more than twice
in a row. After 4 forced choice trials on each lever to establish block contingencies, both levers
were extended upon trial initiation, offering rats a choice between a small safe reward or a large,
risky reward. Each trial began with simultaneous illumination of house and trough lights. Rats
had 10 seconds to initiate a trial via food trough entry, which extinguished the food trough light
and extended either 1 or both levers, depending on trial type.
A press of the safe lever resulted in the delivery of a single food pellet. A risky lever
press delivered 3 food pellets with the risk of a 1 second footshock. Upon lever press and pellet
delivery, levers retracted and the food trough light illuminated. After food was collected or ten
seconds passed, the food trough and house lights were extinguished and an intertrial interval (10s
± 4s) preceded the next trial. The risk of punishment escalated across blocks (0%, 25%, 50%,
75%, 100%). Failure to initiate a trial or press a lever within 10 seconds of instrumental
activation resulted in the trial being marked as an omission and proceeding to the ITI preceding
next trial (Figure 3).
The RDT began with no shock, then once subjects demonstrated preference for the large
reward, risk of shock was added to this reward. Shock intensity increased from .15mA to .35mA
across multiple sessions, as using .35 as the initial shock amplitude can induce an excessive
number of omitted trials and a strong bias away from the large reward during task acquisition (N.
W. Simon & Setlow, 2012). After reaching .35mA, rats continued to perform in the RDT until
stability was achieved over five days, as assessed by an ANOVA using day and block as
repeated measures variables. Total percent choice of the risky reward over the final 5 days
average was used to characterize rats as risk-taking or risk-averse.
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Figure 3. Risky Decision Making Task (RDT).

Impulsive Action
Rats (n=49) were first trained to perform a lever press for a pellet reinforcer. After lever
press, training rats were trained in a differential reinforcement of low rates of responding (DRL)
task to measure impulsive action. During DRL, rats first learned to press a lever for food
reinforcement, then were required to withhold the next lever press for a set number of seconds to
receive the next reinforcer. A lever press during this time period resulted in the timer being reset
(Figure 4). Thus, rats were forced to learn to withhold a prepotent response in order to receive
reinforcement. This response withholding period began at 5 seconds; after reaching stable
performance, it advanced to 10 seconds, then to 20 seconds (DRL-20). Rats performed DRL-20
until they achieve stable responding, quantified as no significant difference in behavior across 3
days. Each session was terminated after 45 minutes. The ratio of correct responses (response
performed after the 20 second waiting period) to total responses on the final day of DRL-20
served as a measure of waiting impulsivity. Therefore, a higher correct response ratio is
associated with lower impulsivity.
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Figure 4. Differential Reinforcement of Low Rates of Desponding (DRL) Task.

Impulsive Choice
Impulsive choice was assessed using a delay-discounting task. As with RDT, rats (n=31)
had an option between a large (3 pellet) and small (1 pellet) reward. However, in the delaydiscounting task, the large reward was delivered after a delay that increases throughout the
session. The session began with a 0 second delay preceding the large reward, which increased
through 4, 8, 16, and 32 seconds over 5 blocks of 10 choice trials each. Each block was preceded
with a forced choice trial on each lever. Stability was assessed over a 5 day period using an
ANOVA. The total percent choice of the delayed reward over a final 5 day average served as a
measure of impulsive choice, or willingness to wait for a larger reward. The delay before large
reward delivery was added to the ITI after small reward delivery to keep trial length consistent
regardless of reward choice (Figure 5).
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Figure 5. Delay Discounting Task.

Habit Formation
Rats (n=25) were then trained in a reinforcer devaluation protocol previously shown to
elicit habitual responding (LeBlanc et al., 2013). Rats ran 1 day of variable ratio 5, in which an
average of five nosepokes resulted in food delivery. Then, rats performed in a variable interval
(VI) task, in which a nosepoke after a variable delay resulted in food delivery. Rats trained for
five days each on VI-5, -10, and -60, with each number indicating the average amount of time
rats must wait to respond per trial. Prior to the following session, rats were given free access to
their reward pellets for 1 hour; this is sufficient to produce reinforcer devaluation (LeBlanc et al.,
2013). Then, rats performed 10 minutes of instrumental behavior during which no reinforcer was
available (extinction), followed by 20 minutes of normal VI-60. Habit formation was quantified
on this probe session using a devaluation ratio equal to responses during extinction divided by
the sum of responses during an equivalent time on the previous day’s VI-60 and during
extinction. A larger devaluation ratio was indicative of ongoing reward seeking despite
reinforcer devaluation, indicative of decreased sensitivity to outcome value and therefore greater
habit formation.
23

Data Analysis
Stable performance on the RDT and Delay discounting was confirmed as no effect of day
or interaction of day by block on reward preference over 5 days through a repeated measures
ANOVA. Stable performance on the DRL was confirmed as no effect of day over 3 days through
a repeated measures ANOVA. Pearson’s correlations were used to search for linear relationships
between the risk preference in the RDT and the primary measure of each behavioral
characteristic. A median split of RDT performance was conducted to categorize rats as risktaking or risk-averse. These groupings were used to further assess and visualize risk-taking and
other behavioral phenotypes through ANOVAs.

Experiment 2: Relationship between risk-taking and nicotine sensitivity
Behavioral Apparatus
Nicotine sensitization was measured using a MedAssociates open field chamber equipped
with a grid of break beams to capture locomotor activity.
Nicotine Sensitization
We measured nicotine-evoked locomotion and sensitization using a previously
established protocol (Bueno-Junior et al., 2017). Briefly, rats (n=19) were placed in the open
field chamber to measure locomotor activity, rearing, and stereotypy for 30 minutes. They then
received a subcutaneous injection of saline, followed by 30 minute in the open field, then another
injection of .2mg/kg nicotine tartrate salt solution, followed by an hour in the open field. This
protocol continued for 5 consecutive days, after which rats underwent an 8-day washout period
with no nicotine. A final probe day then consisted of a final .2 mg/kg nicotine injection.
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Locomotion on the final day of nicotine exposure served as a measurement of locomotor
sensitization after a period of nicotine abstinence.
Data Analysis
Sensitization was confirmed using a paired t-test on the nicotine-evoked locomotion of
day 5 of nicotine treatment and the post washout sensitization probe day. Pearson’s correlations
were used to search for linear relationships between risk preference in the RDT and locomotion
on each day of the protocol. A median split of RDT performance was conducted to categorize
rats as risk-taking or risk-averse. These groupings were used to further assess and visualize risktaking and nicotine sensitivity through ANOVAs. To account for differences in response to i.p.
injections, we calculated a ratio of nicotine-evoked locomotion to saline-evoked locomotion+1
(the +1 was added to avoid possible divide by zero errors).

Experiment 3: Relationship between risk-taking and dopamine dynamics in nucleus
accumbens
Fixed potential amperometry
Real-time dopamine release in the NAc was measured using in vivo fixed potential
amperometry. Rats (n=19) were anaesthetized using two i.p. injections of urethane (1.5g/kg).
They were then be placed on a heating pad to maintain a constant body heat (38 ± 0.1 ºC) and
fixed into a stereotaxic frame, which held all drills, a 3 electrode recording system, and a
stimulating electrode. A stimulating electrode was placed into the ventral tegmental area (VTA;
coordinates from bregma: AP + 3.3mm, ML + 0.3mm, and DV - 4.0mm from dura) (Paxinos &
Watson, 1997). A reference and auxiliary electrode coupling was placed in cortical contact
contralateral to the stimulating electrode. Finally, a carbon fiber microelectrode was placed in an
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area estimated as the NAc shell (AP - 1.5mm, ML + 1.0mm, DV - 4.0mm) and received a fixed
+0.8V current. After insertion of the recording electrode, a 50Hz (20, 0.5ms pulses) electrical
stimulation of the VTA was delivered through the stimulating electrode, resulting in release of
striatal dopamine.
Amperometry sessions began with a measure of phasic dopamine release evoked via
electrical stimulation as well as the synaptic half-life of dopamine following this simulated
phasic dopamine release, defined as latency between peak dopamine release and restoration to
50% of baseline. Next, a subset of rats (n=11) were injected with a half-maximal dose of the
DAT inhibitor nomifensine, while the VTA stimulation continued every 30 seconds. We then
measured dopamine half-life at 20, 40, and 60 minute intervals. Finally, supply of available
dopamine was measured by calculating total dopamine efflux during 3 minutes of continuous
electrical stimulation.
Data Analysis
Data for analysis of evoked dopamine release was extracted between .25s before and 10s
after stimulation. Change in current recordings due to dopamine oxidation served as a measure of
dopamine levels. The recording electrodes were calibrated in vitro using a flow injection system
to convert mean change in dopamine oxidation (nA) to a mean dopamine concentration (uM)
(Prater, Swamy, Beane, & Lester, 2018).
The pre-drug half-life of dopamine served as a measure of DAT efficiency. The percent
change in dopamine half-life from pre to post drug provided a measure of DAT population
density and susceptibility to the presence of a dopamine reuptake inhibitor.
Pearson’s correlations were used to search for linear relationships between risk-taking in
the RDT and dopaminergic characteristics. Risk-taking and risk-averse groupings were split at
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50% risk preference. Group differences in dopaminergic signaling were analyzed using risk
group as the grouping variable in a between subjects ANOVA.

Research Questions and Hypotheses
This thesis proposed a battery of experiments to address several questions regarding the
behavioral and biological mechanisms that contribute to risky behavior. In addition, these
experiments further established the RDT as a task useful for capturing several aspects of
addiction vulnerability through its risk preference characterization.
Experiment 1
Research Question: Will risk-taking rats demonstrate behavioral phenotypes associated with
addiction vulnerability?
Hypothesis: We hypothesize risk-taking rats will exhibit greater impulsive action and habit
formation than risk-averse rats, but show no differences in impulsive choice.
Experiment 2
Research Question: Will risk-taking rats demonstrate enhanced sensitivity to repeated nicotine
exposure?
Hypothesis: We expect risk-taking rats to exhibit increased initial locomotor sensitivity to
nicotine as well as greater nicotine-evoked locomotor sensitization post withdrawal.

Experiment 3
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Research Question: Will risk-taking rats exhibit aberrant dopaminergic signaling in the NAc?
Hypothesis: We expect risk-taking rats to exhibit a hyperdopaminergic phenotype in NAc,
including enhanced evoked dopamine release, increased overall dopamine supply, and reduced
dopamine transporter efficiency.
Results
Experiment 1 Results
Risky Decision-making
For all experiments, rats were trained in RDT to provide an index of baseline risky
decision-making, with the order of tasks counterbalanced across subjects. On average, rats
required 26.18 training sessions to achieve stable responding across five sessions. Percent choice
of the risky reward across a 5-day average served as our measure of risk-taking propensity. In
total, rats demonstrated a repeated measures effect of punishment probability (F (4, 46) = 81.297,
p < .001), with preference shifting away from the large, risky reward being reduced throughout
the session. This indicated that rats discount large rewards as a function of risk of punishment.

Impulsive Action
The distribution of risk-taking scores are depicted in Figure 6a. These were compared
with impulsive action, quantified as correct responses divided by total responses on DRL, with
lower scores indicative of increased impulsivity. A Pearson’s correlation analysis found no
relationship between risk preference and DRL-5sec correct ratio (r = -.112, p = .444, Figure 6b).
However, enhancing task difficulty by lengthening the DRL latency inter-response period
revealed negative correlations between correct ratios and RDT performance (DRL-10sec: r =
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-.368, p = .009, Figure 6c; DRL-20sec: r = -.340, p = .017, Figure 6d), indicating that a
preference for risk-taking predicted high impulsive action. To further explore differences in
impulsive action as a function of risk, we conducted a median split of all subjects based on risk
mean. After grouping subjects into “risk-taking” and “risk-averse” (Figure 6e), a one-way
ANOVA revealed no difference between groups in DRL-5 correct ratio (F (1, 47) = .003, p = .
956, Figure 6f). However, as observed with the correlations, there were significant effects of risk
group on correct ratio during DRL-10 (F (1, 47) = 11.306, p = .002, Figure 6g) and DRL-20 (F
(1, 47) = 7.028, p = .011, Figure 6h), such that rats categorized as risk-taking expressed higher
levels of impulsive action than risk-averse.

Figure 6: Impulsive Action and Risk-Taking. a. Individual variability in RDT performance. b-d.
Scatterplots depicting relationship between risk-taking and impulsive action. Lower DRL ratio
scores (x-axis) indicate greater impulsivity. There was no correlation between risk-taking and
DRL-5 accuracy (b), but there were significant negative correlations between DRL-10 and 20
accuracy and risk-taking, such that high risk-taking predicted high impulsive action (c-d). e.
RDT means for risk-taking and risk-averse groups. f-h. Group differences in DRL correct ratio.
There was no difference in DRL-5 between groups (f), but risk-taking rats were more impulsive
on both DRL-10 (g) and DRL-20 (h).
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Impulsive Choice
Percent choice of the large, delayed reward averaged across the final 5-days of training
served as our measure of impulsive choice. Collectively, rats demonstrated a repeated measures
effect of delay (F (4, 27) = 112.352, p < .001), indicating discounting of the large reward as a
function of delay. The distribution of risk-taking scores are depicted in Figure 7a. We observed
no relationship between risk-taking and impulsive choice, reflected by a lack of significant
correlation between measures (r = -.074, p = .692, Figure 7b) and no group difference in
impulsive choice between risk-taking and risk-averse rats (F (1, 29) = .238, p = .629, Figure 7cd). In addition, there were no correlations between delay discounting and any schedule of DRL
(DRL-5/DD: r = -.066, p = .725; DRL-10/DD: r = .121, p = .516; DRL-20/DD: r = .176, p = .
345), indicating that impulsive action did not predict impulsive choice.
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Figure 7: Impulsive Choice and Risk-Taking. a. Individual variability in RDT performance. b.
Scatterplot depicting relationship between risk-taking and impulsive choice. Lower preference
for the delayed reward (x-axis) indicates greater impulsivity. There was no correlation between
risk-taking and delay discounting. c. RDT means for risk-taking and risk-averse groups. d. Group
differences in delay discounting. There was no difference in delay discounting between risk
groups.

Habit Formation
Habit formation was measured using reinforcer devaluation, then compared with RDT
performance (Figure 8a). Responses during extinction following devaluation by satiation were
significantly reduced from an equivalent 10 minute baseline on the previous session of VI-60 (t
(24) = 7.673, p < .001). This reduction from baseline persisted after the reinforcer was
reintroduced 10 minutes into the probe session (t (24) = 2.853, p = .009). Habit formation,
defined here as the ratio between the extinction session and baseline responding, was not
correlated with risky decision-making (r = -.195, p = .351, Figure 8b), nor did habit formation
differ between median split risk groups (F (1, 23) = .308, p = .584, Figures 8c-d).
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Figure 8: Habit Formation and Risk-Taking. a. Individual variability in RDT performance. b.
Scatterplot depicting relationship between risk-taking and habit formation, with higher
devaluation ratios (x-axis) indicating greater habit formation. There was no correlation between
risk-taking and habit formation. c. RDT means for risk-taking and risk-averse groups. d. Group
differences in habit formation. There was no difference in habit formation between groups.

Experiment 2 Results
Comparison of Nicotine Sensitization and Risky Decision-making
Rats were characterized in RDT (Figure 9a), then tested in locomotor sensitivity to
nicotine. There was no significant difference in nicotine-evoked locomotor activity across the
five initial nicotine sessions (F (1, 18) = .764, p =.484; Figure 9b). However, all rats
demonstrated an increase in nicotine-evoked locomotion on the final day of nicotine exposure,
confirmed by a paired-sample t-test day 5 and on the test session after nine days of abstinence (t
(18) = -6.264, p < .001, Figure 9b). This indicated that our protocol was sufficient to induce
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locomotor sensitization to nicotine.

Figure 9: Risk-Taking and Nicotine Sensitization. a. Individual variability in RDT performance.
b. Mean distance traveled for each nicotine exposure session. There was a significant difference
in distance traveled between session 5 of nicotine and the sensitization session after a nine-day
abstinence, indicative of locomotor sensitization to nicotine.

Risk-taking and measures of nicotine sensitivity were compared both by Pearson’s
correlation and by dividing groups into risk-taking and risk-averse, as in previous experiments.
There was a significant correlation between nicotine-evoked locomotion and risk-taking on the
first day of nicotine treatment (r = .506, p = .038, Figure 10a), suggesting that risk-taking is
associated with increased sensitivity to the locomotor activating effects of nicotine. In addition,
there was a near-significant trend suggesting that risk-takers were more sensitive than risk-averse
to first-time nicotine exposure (F (1, 14) = 3.398, p = .087, Figure 10b). Interestingly, this
predictive relationship was only observed upon the first nicotine exposure, with no significant
correlations between RDT and nicotine-evoked locomotion on any of the four subsequent
sessions, and no difference between risk groups in locomotion (Table 1). Furthermore, risk33

taking was not predictive of nicotine locomotor sensitization following withdrawal (r = .170, p
= .513).
As the relationship between risk-taking and nicotine-evoked locomotion was only evident
during initial exposure to nicotine, further statistical analyses were restricted to this session. To
confirm that increased locomotor sensitivity to first-time nicotine was not a product of
differential sensitivity to i.p. injection, we compared RDT performance with a ratio of nicotineevoked to saline-evoked locomotion. The correlation between risk-taking and nicotine sensitivity
was still present after baseline locomotion was accounted for via this ratio measure (r = .523, p =
.031, Figure 10c).

Figure 10: Risk-taking and sensitivity to nicotine: a. There was a significant positive correlation
between risk-taking and nicotine-evoked locomotion on session one. b. There was a near
significant difference in locomotion evoked by the first nicotine exposure, but no differences or
trends between groups in subsequent sessions. c. There was a significant positive relationship
between risk-taking and the ratio between nicotine- and saline-evoked locomotion.

Nicotine session
Day 1
Day 2
Day 3
Day 4

Correlation
r = .506, p =.038*
r =.-.049, p = .853
r = -.223, p =.389
r = -.138, p = .597
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Risk group difference
F (1, 14) = 3.398, p = .087
F (1, 14) = .124, p = .730
F (1, 14) = .693, p =.419
F (1, 14) = .933, p = .350

Day 5
r = -.120, p = .647
F (1, 14) = .073, p = .856
Sensitization
r = .170, p = .513
F (1, 14) = .034, p = .856
Table 1: Statistical relationships between nicotine-induced locomotion and risk-taking.

One possible explanation for risk-taking predicting higher levels of first-time nicotineevoked locomotion is a diminished response to the anxiogenic effects of nicotine (Casarrubea et
al., 2015). To explore this possibility, we assessed total distance traveled in the center of the
open field, which is associated with lower levels of anxiety (P. Simon, Dupuis, & Costentin,
1994). We found a positive correlation between risk-taking and movement in center after
nicotine (r = .589, p = .013, Figure 11a), suggesting that risk-preference on RDT was associated
with reduced susceptibility to the anxiogenic effects of first-time nicotine. This was supported
further by the observation that risk-taking rats showed greater activity in the center of the field
than risk-averse rats (F (1, 14) = 13.117, p = .003, Figure 11b). To control for this effect being an
artifact of increased overall locomotion, we compared risk-taking with a ratio of time in center to
total locomotion and observed a strong trend toward correlation between risk-taking and this
ratio measure (r = .437, p = .079, Figure 11c). Additionally, a one-way ANOVA revealed risktaking rats had significantly high scores on this measure (F (1, 14) = 9.785, p = .023, Figure
11d). Collectively, these data demonstrate that risk-taking is predictive of increased locomotion
evoked by first-time nicotine exposure, and that this locomotor activation may be related to
decreased sensitivity to the anxiogenic effects of first-time nicotine exposure.
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Figure 11: Risk-Taking and First-Time Nicotine Exposure: a. There was a significant positive
correlation between risk-taking and distance traveled in center, a measure of reduced anxiety. b.
Risk-taking rats showed greater time in the center of the field after nicotine compared to riskaverse. c. There was a near significant positive correlation between risk-taking and the ratio
between time in center and total nicotine-evoked locomotion. d. Risk-taking rats demonstrated a
higher ratio between time in center and total locomotion compared to risk-averse.

Experiment 3 Results
Comparison of risk-taking and dopamine dynamics in the nucleus accumbens shell
Rats were initially characterized in the RDT as risk-taking or risk-averse based on total
percent choice of the risk reward (Figure 12a-b).
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Figure 12: Risk-taking behavior of rats prior to fixed potential amperometry. a. Individual
variability in RDT performance. b. RDT means for risk-taking and risk-averse groups.

Fixed potential amperometry (FPA) was used to detect differences in dopamine release dynamics
in the nucleus accumbens (NAc) between risk-taking and risk-averse rats. First, we measured
VTA stimulation-evoked dopamine efflux in the NAc. Histology revealed accurate placement of
the stimulating electrodes the VTA (AP: -4.16mm to -4.80mm, ML: +1.1mm to +2.2mm, DV:
-7.4mm to -9.6mm; Figure 13).
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Figure 13: Location of VTA stimulations. Grey ovals represent location of VTA at 3 different
AP coordinates. Black ovals represent locations of stimulating electrodes, identified via lesions.

A one-way ANOVA revealed significantly elevated dopamine release in risk-taking rats relative
to risk averse rats (F (1, 18) = 14.85, p < .001, Figure 14a-b). There was also a positive
correlation between risk preference and baseline dopamine-release (r = .522, p =.022, Figure
14c). There was no difference in dopamine half-life between risk-taking and risk-averse rats at
baseline (F (1, 18) = .78, p = .38, Figure 14d) and no correlation between risk-taking and
dopamine half-life (r = -.203, p = .405). Dopamine supply was determined by running a
continuous 50 HZ stimulation train over 3 minutes to evoke the release of all available dopamine
in the NAc. Analyses indicated a trend toward increased dopamine supply in risk-taking relative
to risk-averse rats (F (1, 18) = 3.94, p = .07 Figure 14e). Additionally, there was a trend towards
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a significant correlation between risk-taking and dopamine supply (r = .582, p =.06, Figure 14f).

Figure 14: Risk-Taking and Dopaminergic Characterization. * denotes significance. + denotes
near significance. a. Risk-taking rats exhibited elevated baseline phasic release in NAc following
VTA stimulation. b. Representative example traces of phasic NAc dopamine efflux for risktaking and risk-averse rats. c. There was a significant positive correlation between risk-taking
and baseline phasic dopamine release. d. There was no difference in baseline dopamine half-life
between risk groups. e. There was a near significant group difference in overall dopamine
supply. f. There was a near significant positive correlation between risk-taking and dopamine
supply.

Next, we measured sensitivity to the dopamine transporter (DAT) inhibitor nomifensine
as a function of risk-preference. This was determined by measuring the % change in dopamine
half-life from baseline at 20 minute intervals for one hour post nomifensine administration.
Analyses revealed a significant risk group x time point interaction (F (3, 27) = 2.99, p = 0.04) on
dopamine half-life in the NAc following nomifensine. A subsequent one-way ANOVA revealed
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that dopamine half-life was significantly enhanced in risk-taking rats 40 minutes (F = 6.752, p
= .029, Figure 15a) and 60 minutes post nomifensine (F = 7.008, p = .027, Figure 15a).
Additionally, we observed significant correlations between risk preference and % change in
dopamine half-life at both 40 minutes (r = .718, p = .013, Figure 15b) and 60 minutes post
injection (r = .739, p = .009, Figure 15c).

Figure 15: Risk-taking and nomifensine sensitivity. a. There were significant differences in
percent change in dopamine half-life between risk-taking and risk averse rats at 40 and 60
minutes post nomifensine. b, c. There was a significant positive correlation between risk-taking
and percent change in dopamine half-life at the 40 and 60 minute time points.
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Discussion
Excessive risky decision-making is common in multiple psychiatric disorders, including
substance abuse disorder (Bechara et al., 2001). In this thesis, I examined addiction-relevant
behavioral and neurochemical phenotypes associated with risk-taking as quantified by the RDT.
In experiment 1, I observed that risk-taking rats exhibit elevated impulsive action, but not
impulsive choice or habit formation. In experiment 2, I found that risk-taking rats exhibit high
locomotor sensitivity to first-time nicotine exposure, and that this is likely related to a reduction
in nicotine-evoked anxiety. In experiment 3, I examined the dopaminergic signaling
characteristics of risk-taking rats and found them to be hyper-dopaminergic compared to risk
averse subjects. Specifically, risk-takers demonstrated increased phasic dopamine release in
NAc, a trend toward greater overall dopamine supply, and increased sensitivity to the dopamine
transporter (DAT) inhibitor nomifensine. Collectively, these data provide evidence that the RDT
predicts a cluster of phenotypes associated with addiction-vulnerability, while also providing
novel insight regarding the mechanisms that promote risk-taking.

Experiment 1: Cognition
These data indicate that risk-taking is associated with deficient inhibitory control, a trait
referred to as motor impulsivity which is predictive of substance abuse in humans (Olmstead,
2006). This relationship was only observed in higher DRL schedules (10 and 20 sec), suggesting
that differences in impulsivity only manifest under higher cognitive demand. The predictive
linear relationship between risk-taking and impulsive action suggests that persistent, inflexible
risk-taking may be related to an inability to appropriately suppress a response despite inflating
risk of punishment.
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The comorbidity between impulsive action and risk-taking may arise from specific
patterns of dopamine receptor expression. Elevated D1 receptor expression in NAcs has
previously been identified as a biomarker of both risk-taking in RDT (N. W. Simon et al., 2011)
and impulsive action in DRL (N. W. Simon et al., 2013) suggesting NAc as a potential locus
driving both behaviors. Indeed, NAc lesions have been shown to increase impulsive action (R. N.
Cardinal, Pennicott, Sugathapala, Robbins, & Everitt, 2001). D1 receptors are associated with
increased motivation for natural rewards (Rolls et al., 1974; Rusk & Cooper, 1994), suggesting
that comorbidity between excessive impulsivity and risk-taking may be driven at least in part by
reward motivation. However, previous data revealed that risk-taking was uncorrelated with
reward seeking or consumption (Simon et al., 2011), and that manipulating levels of motivation
(via enhancing reward magnitude or inducing satiation) did not alter risk preference (Shimp et
al., 2015; N. W. Simon et al., 2009). Thus, baseline risk-taking appears to be independent of
motivation.
Other possible explanations for the difference in impulsive action between risk groups is
that risk-takers were unable to comprehend the parameters of the DRL task due to lower overall
cognitive capacity, or insufficient engagement in the task. This is unlikely, as risk-taking was not
associated with performance on the DRL-5, a less demanding version of DRL. This
demonstrated that risk-takers were able to sufficiently learn the parameters of DRL, and only
displayed differences when the “wait time” between responses was sufficient to drive impulsivity
(10 or 20 sec). Additionally, previous research has found that low working memory is in fact
associated with hyper risk aversion rather than preference in the RDT (Shimp et al., 2015).
Finally, in humans, risk-taking is typically dissociable from measures of executive function and
intelligence (Toplak, Sorge, Benoit, West, & Stanovich, 2010). Therefore, it is unlikely that the
comorbidity between risk-taking and impulsive action is driven by overall intelligence or task
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comprehension.
No relationship was observed between risk-taking on RDT and impulsive choice, which
is consistent with previous data in rat models using comparable measures (Shimp et al., 2015; N.
W. Simon et al., 2009). While humans with substance use disorders commonly exhibit comorbid
exacerbations of risk-taking and impulsive choice (Bickel, Koffarnus, Moody, & Wilson, 2014;
Brand et al., 2008; Lane & Cherek, 2000; Murphy et al., 2012), these measures are often
uncorrelated (Andrade & Petry, 2012). The results of this experiment support the argument that
reduction in economic value during decision-making does not always follow a unitary system,
instead varying based on the modality of the factor that devalues the reward (risk for RDT, delay
for delay discounting) (Green & Myerson, 2004). Furthermore, previous data have revealed
differences in the neural substrates underlying the processing of punishment risk and delay
during decision-making. For example, basolateral amygdala lesions reduce preference for the
discounted reward in delay discounting, but enhance preference in RDT (C. A. Orsini et al.,
2015; C. A. Winstanley, 2004). This task-specific differences is also evident at the receptor level,
as D1 receptors in the INS are associated with diminished delay discounting, but elevated risktaking (Pattij, Schetters, & Schoffelmeer, 2014; N. W. Simon et al., 2011).
Habit formation, measured here via reinforcer devaluation, did not differ as a function of
risk-taking. This implies that risk-taking rats shift from goal-directed to habitual reward at a rate
comparable to risk-averse, indicating that perseverative selection of the large, risky reward was
likely not related to inability to adjust behavior in accordance with changing action-outcome
contingencies. This contrasts with the previous finding of diminished D2 receptor population in
the DS of risk-takers, which was expected to predict elevated habit formation via striatal
disinhibition (Barry J. Everitt & Robbins, 2016; Obadiah et al., 1999; N. W. Simon et al., 2011).
However, this previous study did not discriminate between different subregions of dorsal
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striatum. Therefore, it is possible that the alterations in D2 expression were not localized to
dorsolateral striatum, which is associated with development of habitual behavior (Robbins et al.,
2008; Yin, Knowlton, & Balleine, 2004)
Experiment 2: Nicotine
Risk-taking was associated with elevated locomotor sensitivity to the first exposure to
nicotine, with no relationship between locomotor activation and risk-taking observed across any
subsequent nicotine exposure. Rats demonstrated locomotor sensitization to nicotine after a
period of abstinence, which was anticipated based on the nicotine dose and schedule utilized here
(Bueno-Junior et al., 2017). Contrary to our hypothesis, there was no difference in the degree of
sensitization based on risk-taking, indicating that the predictive relationship between risk-taking
and nicotine sensitivity is limited to the initial exposure.
Initial response to nicotine is a reliable predictor of prolonged nicotine abuse in humans
(DiFranza et al., 2004; Eissenberg & Balster, 2000; Hu, Davies, & Kandel, 2006). Initial
cigarette consumption is typically both anxiogenic and physically aversive (Bewley, Bland, &
Harris, 1974; Newhouse et al., 1990), but chronic smokers report experiencing less aversive
effects, enhancing the likelihood of continued nicotine abuse (Eissenberg & Balster, 2000). Here,
we observed that risk-taking rats were more sensitive to locomotor-activating effects of first-time
nicotine. Furthermore, risk-taking was associated with reduced anxiety evoked by first time
nicotine, as reflected by increased time in the center of the open field. This is likely not a result
of lower baseline anxiety in risk-taking rats, as previous research has shown risk-taking and riskaverse rats to not differ in measures of trait anxiety (N. W. Simon et al., 2011). Collectively,
these data suggest that risk-taking rats resemble chronic nicotine abusers in their resilience
against the anxiogenic effects of first-time nicotine.
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Enhanced nicotine-evoked locomotor activity in risk-takers may also be related to
enhanced sensitivity to nicotine’s rewarding properties, as locomotion is often predictive of
reward and dopamine release (Gaetano Di Chiara, 2000). Nicotine reward is mediated by D1
receptors in the mesolimbic pathway (Corrigall, Franklin, Coen, & Clarke, 1992; Hall, Slade,
Allenby, Kutlu, & Levin, 2015), and D1 receptor expression is elevated in the NAc of risk-taking
rats (N. W. Simon et al., 2011). Risk-taking rats also exhibit elevated D1 receptors in the INS (N.
W. Simon et al., 2011) and blockade of D1 in the INS has been shown to decrease nicotine selfadministration (Kutlu et al., 2013). These previous data in concert with the enhanced nicotineevoked locomotion observed here indicate that risk-taking rats may experience elevated
sensitivity to nicotine reward.

Experiment 3: Amperometry
Using fixed potential amperometry, we examined in vivo dopaminergic signaling in the
NAc of rats characterized in the RDT. The NAc receives dopaminergic projections from the
ventral tegmental area (VTA), and dopamine release and receptor binding in this pathway is
involved with motivation and is modulated by drugs of abuse (Cooper, Robison, & MazeiRobison, 2017; G. Di Chiara & Imperato, 1988; Wise, 1989). While risk-taking on RDT has
been associated with dopamine receptor expression in NAc ex vivo (Mitchell et al., 2014; N. W.
Simon et al., 2011), little is known about the relationship between risk-taking and biologically
relevant dopamine signaling. Here, we observed that VTA stimulation-evoked dopamine release
is enhanced in risk-taking compared to risk-averse rats. This stimulation protocol causes phasic
dopamine activity, which is induced in behaving subjects by burst firing of dopamine neurons in
the midbrain in response to rewards and reward-predictive stimuli (Floresco et al., 2003; Ikemoto
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& Panksepp, 1999; Schultz, 1998). Elevated phasic dopamine release suggests that risk-taking
rats may be more susceptible to the motivational effects of rewards and reward-predicting
stimuli. This is consistent with the observation that risk-taking rats attribute greater salience to
reward-predictive cues, manifested as elevated sign-tracking (Olshavsky et al., 2014). These data
also suggest that the previously observed abundance of D1 receptors in the NAc of risk-taking
rats may be a response to enhanced dopamine activity in the region (N. W. Simon et al., 2011).
Thus, risk-taking rats may be more vulnerable to the motivational effects of both natural rewards
and dopaminergic drugs of abuse, thereby driving addiction vulnerability.
It is possible that elevated phasic dopamine response was a result of reduced dopamine
reuptake in risk-taking rats. However, there were no differences between groups in dopamine
half-life, defined as latency between peak dopamine release and restoration to 50% of baseline.
Dopamine half-life is related to DAT efficiency, with a shorter half-life being indicative of
greater efficiency (Benoit-Marand, Jaber, & Gonon, 2000; Mittleman et al., 2011), suggesting
that reuptake following dopamine release does not vary as a function of risk-taking phenotype. In
addition, we observed a near-significant trend toward enhanced dopamine supply in risk-taking
rats. This enhanced supply may be a compensatory mechanism resulting from elevated phasic
dopamine release, although further experimentation is necessary to confirm the causal direction
of this relationship.
Risk-taking rats also demonstrated elevated sensitivity to the DAT inhibitor nomifensine,
reflected as increased dopamine half-life after VTA stimulation. This may be another indicator of
vulnerability to drugs of abuse in the risk-taking subpopulation. Elevated sensitivity to
nomifensine translates to increased sensitivity to dopaminergic drugs of abuse that affect DAT,
which include cocaine and amphetamine (Carboni et al., 1989; Kuczenski & Segal, 1989;
Mcelvain & Schenk, 1992). Consistent with this finding, risk-taking rats have previously been
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shown to self-administer more cocaine than risk-averse rats (Mitchell et al., 2014). A possible
explanation for increased sensitivity to nomifensine is diminished DAT capacity (Mittleman et
al., 2011). However, this is unlikely due to the similarities in dopamine half-life prior to
nomifensine. A more plausible explanation is that elevated post-nomifensine half-life is a
function of elevated phasic dopamine release and/or supply causing a greater concentration of
dopamine to flood the synapse, requiring an extended half-life for clearance.
Previous studies have also examined the relationship between dopamine release in NAc
and risk-taking. Dopamine efflux in NAc, measured via microdialysis, has been shown to track
preference for risky rewards (J. R. St. Onge, Ahn, Phillips, & Floresco, 2012). In addition, phasic
dopamine release scales with probability of reward delivery (Fiorillo, Tobler, & Schultz, 2003;
Sugam et al., 2012), and stimulation of D2 receptor containing cells in NAc was sufficient to
shift risk-taking rats toward risk-aversion (Zalocusky et al., 2016). Because D2 receptors are
primarily inhibitory (Obadiah et al., 1999), this implicates the NAc in driving risk-taking
behavior. While these data further validate the role of NAc dopamine in risk-taking, they each
utilized the probability discounting task, which operationalizes risk differently than RDT.
Probability discounting defines risk as probability of reward omission, whereas RDT utilizes
probability of punishment (Caitlin A. Orsini et al., 2015) and is designed to model situations in
which reward is consistently delivered, but there is a chance that a negative outcome may occur.
This punishment-driven risk taking can be more readily extrapolated to the risk taking performed
during substance abuse. The distinction between these forms of risk-taking is further supported
by divergent effects of pharmacological and neurobiological manipulations. Systemic
amphetamine administration has been found to decrease risk-taking in the RDT (N. W. Simon et
al., 2011), but increase risk-taking in probability discounting (Jennifer R. St. Onge & Floresco,
2009), and a similar dichotomy between tasks was observed with direct D2 receptor activation
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(N. W. Simon et al., 2011; Jennifer R. St. Onge & Floresco, 2009). Moreover, inactivation of the
basolateral amygdala increases risk-taking in the RDT, and attenuates risk-taking in probability
discounting (Caitlin A. Orsini et al., 2015). Finally, OFC inactivation attenuates risk-taking in
the RDT (C. A. Orsini et al., 2015), and increases risk-taking in probabilistic discounting (Caitlin
A. Orsini et al., 2015; Stopper, Green, & Floresco, 2014). While our dopaminergic results are
consistent with Sugam 2012’s probability discounting results, we offer here a novel insight risktaking in the RDT’s relationship to baseline dopaminergic activity. Additionally, based on other
dichotomous behavioral and biological findings between the RDT and probability discounting,
there are still likely differences in encoding types of risk based on dopamine sensitivity.

Conclusions and Implications
We observed comorbidity between risk-taking and 1.) impulsive action, 2.) locomotor
sensitivity to first-time nicotine exposure, 3.) reduced anxiety evoked by first-time nicotine, 4.)
elevated nucleus accumbens phasic dopamine release, and 5.) dopaminergic sensitivity to a DAT
inhibitor. These data complement previous data showing that risk takers attribute greater salience
to reward-predicting cues (Olshavsky et al., 2014), self-administer more cocaine in adolescence
(Mitchell et al., 2014), show elevated D1 receptor populations in the NAcs and INS, and
demonstrate D2 receptor abundance in the DS (Simon et al, 2011). Collectively, these data
demonstrate that RDT can serve as a powerful tool for identifying multiple (but not all)
addiction-relevant characteristics with a single behavioral assay. In addition, these data provide
novel information on how pathology within mesolimbic dopamine circuitry can bias some
individuals toward risk-taking behavior.
As only a subset of individuals who use illicit drugs develop substance abuse disorders, it
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is critical to identify factors that engender the transition from casual drug abuse to addiction. The
RDT is a preclinical model that not only measures an addiction-relevant form of risk-taking, but
also detects multiple other behavioral and biological addiction-relevant phenotypes. The ability
to pinpoint a vulnerable population in rats will facilitate the identification of biomarkers and
genetic influences that promote addiction vulnerability, with the goal of being able to detect
vulnerable individuals prior to the onset of pathology.
These data suggest NAc phasic dopamine release as a potential therapeutic target for
pathological risk-taking. Additionally, future research will identify the functional neuronal
activity in NAc and other relevant brain regions that bias vulnerable individuals toward risktaking and the comorbid traits identified in this thesis. This may have utility for development of
precise treatments that attenuate pathological risk-taking as well as sensitivity to drugs of abuse.
This thesis provides a firm foundation for the RDT to serve as a useful tool in future addiction
research as well as development of addiction treatments and interventions.
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